A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

A good night’s sleep often sets the stage for a positive day. But for the nearly quarter of American adults struggling with ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia. ‘Altered opioid neurotransmitter function in the brain may play a key role in anorexia nervosa ...